Sherblom A P, Dahlin C E
J Biol Chem. 1985 Feb 10;260(3):1484-92.
The MAT-B1 and MAT-C1 ascites sublines of the 13762 rat mammary adenocarcinoma, which differ in several cell surface properties, contain a major mucin-type glycoprotein, termed ASGP-1. The sialic acid content of MAT-C1 ASGP-1 is 2-3-fold greater than MAT-B1 ASGP-1 (Sherblom, A. P., Buck, R. L., and Carraway, K. L. (1980) J. Biol. Chem. 255, 783-790). Sialic acid analysis demonstrated that, whereas MAT-C1 ASGP-1 contained approximately equal amounts of N-acetylneuraminic acid (NeuAc) and N-glycolylneuraminic acid (NeuGl), MAT-B1 ASGP-1 was devoid of NeuGl. MAT-B1 microsomes also did not contain NeuGl. MAT-B1 cells incubated with [3H]N-acetylmannosamine did not synthesize either labeled CMP-NeuGl or free NeuGl, even though the CMP-sialic acid synthetase was active with the substrate NeuGl. Thus, MAT-B1 cells may be deficient in the enzyme N-acetylneuraminate monooxygenase. The O-linked oligosaccharides from both MAT-B1 and MAT-C1 ASGP-1 have been shown to contain a core tetrasaccharide Gal(beta 1-4)GlcNAc(beta 1-6)(Gal(beta 1-3]GalNAc in which both galactose residues may be linked to additional sugars (Hull, S. R., Laine, R. A., Kaizu, T., Rodriquez, I., and Carraway, K. L. (1984) J. Biol. Chem. 259, 4866-4877). The distribution of NeuAc and NeuGl between the two galactose termini of the core tetrasaccharide was examined for MAT-C1 ASGP-1. Oligosaccharides were released by alkaline-borohydride treatment of MAT-C1 ASGP-1 which had been labeled with [14C]glucosamine and galactose oxidase/B3H4. Following fractionation by Bio-Gel P-4, DEAE-Sephadex, and high-performance liquid chromatography, oligosaccharides were analyzed for NeuAc and NeuGl and for susceptibility to digestion with beta-galactosidase. Three disialylated oligosaccharides were identified containing 2 mol of NeuAc (5.5% recovery), 2 mol of NeuGl (4.5%), or 1 mol each of NeuAc and NeuGl (11.1%). For monosialylated oligosaccharides, NeuGl appeared preferentially associated with the Gal(beta 1-4)GlcNAc terminus (9.0%), whereas significant amounts of oligosaccharide containing NeuAc at both the Gal(beta 1-3)GalNAc (2.6%) and Gal(beta 1-4)GlcNAc (4.5%) termini were detected. Each of the major qualitative differences between MAT-B1 and MAT-C1 oligosaccharides, including the presence of NeuGl (MAT-C1), sulfate (MAT-B1), and alpha-linked galactose (MAT-B1), occurs at the Gal(beta 1-4)GlcNAc terminus.
13762大鼠乳腺腺癌的MAT - B1和MAT - C1腹水亚系在几种细胞表面特性上存在差异,它们都含有一种主要的粘蛋白型糖蛋白,称为ASGP - 1。MAT - C1 ASGP - 1的唾液酸含量比MAT - B1 ASGP - 1高2 - 3倍(Sherblom, A. P., Buck, R. L., and Carraway, K. L. (1980) J. Biol. Chem. 255, 783 - 790)。唾液酸分析表明,MAT - C1 ASGP - 1含有大约等量的N - 乙酰神经氨酸(NeuAc)和N - 羟乙酰神经氨酸(NeuGl),而MAT - B1 ASGP - 1不含NeuGl。MAT - B1微粒体也不含NeuGl。用[³H]N - 乙酰甘露糖胺孵育的MAT - B1细胞,即使CMP - 唾液酸合成酶对底物NeuGl有活性,也不合成标记的CMP - NeuGl或游离的NeuGl。因此,MAT - B1细胞可能缺乏N - 乙酰神经氨酸单加氧酶。MAT - B1和MAT - C1 ASGP - 1的O - 连接寡糖已被证明含有核心四糖Gal(β1 - 4)GlcNAc(β1 - 6)[Gal(β1 - 3]GalNAc,其中两个半乳糖残基都可能与其他糖相连(Hull, S. R., Laine, R. A., Kaizu, T., Rodriquez, I., and Carraway, K. L. (1984) J. Biol. Chem. 259, 4866 - 4877)。对MAT - C1 ASGP - 1核心四糖的两个半乳糖末端之间的NeuAc和NeuGl分布进行了研究。用[¹⁴C]葡萄糖胺和半乳糖氧化酶/B³H⁴标记的MAT - C1 ASGP - 1经碱性硼氢化物处理释放寡糖。通过Bio - Gel P - 4、DEAE - 葡聚糖凝胶和高效液相色谱分级分离后,对寡糖进行NeuAc和NeuGl分析以及对β - 半乳糖苷酶消化的敏感性分析。鉴定出三种双唾液酸化寡糖,分别含有2摩尔NeuAc(回收率5.5%)、2摩尔NeuGl(4.5%)或各1摩尔NeuAc和NeuGl(11.1%)。对于单唾液酸化寡糖,NeuGl似乎优先与Gal(β1 - 4)GlcNAc末端结合(9.0%),而在Gal(β1 - 3)GalNAc(2.6%)和Gal(β1 - 4)GlcNAc(4.5%)末端都含有NeuAc的寡糖也有大量检测到。MAT - B1和MAT - C1寡糖之间的每个主要定性差异,包括NeuGl的存在(MAT - C1)、硫酸盐(MAT - B1)和α - 连接的半乳糖(MAT - B1),都发生在Gal(β1 - 4)GlcNAc末端。